REQUEST A DEMO
Total
USD $0.00
Search more companies

Lustre Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Lustre Pharmaceuticals Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Lustre Pharmaceuticals Private Limited is an unlisted company, incorporated on 24/03/2003. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24231GJ2003PTC042154 and registration number is 042154. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
15, Barcelona Industrial Estate, Sardar Patel Ring Road, Odhav Circle, Odhav,
Ahmedabad; Gujarat; Postal Code: 382415

Contact Details: Purchase the Lustre Pharmaceuticals Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Lustre Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Lustre Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
March 24, 2003
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Lustre Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-11.89%
Total operating revenue
-11.85%
Operating profit (EBIT)
-14.78%
EBITDA
-12.55%
Net Profit (Loss) for the Period
8.18%
Total assets
13.24%
Total equity
20.17%
Operating Profit Margin (ROS)
-0.33%
Net Profit Margin
1.49%
Return on Equity (ROE)
-1.86%
Debt to Equity Ratio
8.36%
Quick Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?